GnRH and sex steroids play an important role in immune system modulation and development. GnRH and the GnRH receptor are produced locally by immune cells, suggesting an autocrine role for GnRH. Experimental studies show a stimulatory action of exogenous GnRH on the immune response. The immune actions of GnRH in vivo are, however, less well established. Oestrogen and androgen receptors are expressed in primary lymphoid organs and peripheral immune cells. Experimental data have established that oestrogens enhance the humoral immune response and may have an activating role in autoimmune disorders. Testosterone enhances suppressor T cell activity. Although there are some clinical studies consistent with these findings, the impact of sex steroids in autoimmune disease pathogenesis and the risk or benefits of their usage in normal and autoimmune-disordered patients remain to be elucidated. There are neither experimental nor clinical data evaluating functional GnRH-sex steroid interactions within the human immune system, and there is a paucity of data relating to GnRH analogues, hormone replacement therapy and oral contraceptive and androgen action in autoimmune diseases. However, a growing body of experimental evidence suggests that an extra-pituitary GnRH immune mechanism plays a role in the programming of the immune system. The implications of these findings in understanding immune function are discussed.

This article has been cited by other articles:

				A. Maccio, C. Madeddu, E. Sanna, F. Panzone, A. Volpe, and G. Mantovani Evidence that Human Serum with High Levels of Estrogens Interferes with Immune System Both by Decreasing CD25 Expression on T-Cell and by Increasing Interleukin-2 Availability Reproductive Sciences, November 1, 2008; 15(9): 961 - 969. [Abstract] [PDF]

				D. E. Keil, T. Mehlmann, L. Butterworth, and M. M. Peden-Adams Gestational Exposure to Perfluorooctane Sulfonate Suppresses Immune Function in B6C3F1 Mice Toxicol. Sci., May 1, 2008; 103(1): 77 - 85. [Abstract] [Full Text] [PDF]

				K. Walters, I. N. Wegorzewska, Y.-P. Chin, M. G. Parikh, and T. J. Wu Luteinizing Hormone-Releasing Hormone I (LHRH-I) and Its Metabolite in Peripheral Tissues Experimental Biology and Medicine, February 1, 2008; 233(2): 123 - 130. [Abstract] [Full Text] [PDF]

				L. Faulkner, D. M. Altmann, S. Ellmerich, I. Huhtaniemi, G. Stamp, and S. Sriskandan Sexual Dimorphism in Superantigen Shock Involves Elevated TNF-{alpha} and TNF-{alpha} induced Hepatic Apoptosis Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 473 - 482. [Abstract] [Full Text] [PDF]

				B. Lutton and I. Callard Evolution of reproductive-immune interactions Integr. Comp. Biol., December 1, 2006; 46(6): 1060 - 1071. [Abstract] [Full Text] [PDF]

				H. Zhang, J. S. Bailey, D. Coss, B. Lin, R. Tsutsumi, M. A. Lawson, P. L. Mellon, and N. J. G. Webster Activin Modulates the Transcriptional Response of LssT2 Cells to Gonadotropin-Releasing Hormone and Alters Cellular Proliferation Mol. Endocrinol., November 1, 2006; 20(11): 2909 - 2930. [Abstract] [Full Text] [PDF]

				A. Tirosh, D. Mandel, F. B. Mimouni, E. Zimlichman, T. Shochat, and I. Kochba Autoimmune diseases in asthma. Ann Intern Med, June 20, 2006; 144(12): 877 - 883. [Abstract] [Full Text] [PDF]

				J J Corrales, M Almeida, R Burgo, M T Mories, J M Miralles, and A Orfao Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency. J. Endocrinol., June 1, 2006; 189(3): 595 - 604. [Abstract] [Full Text] [PDF]

				S. T. Page, S. R. Plymate, W. J. Bremner, A. M. Matsumoto, D. L. Hess, D. W. Lin, J. K. Amory, P. S. Nelson, and J. D. Wu Effect of medical castration on CD4+CD25+ T cells, CD8+ T cell IFN-{gamma} expression, and NK cells: a physiological role for testosterone and/or its metabolites Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E856 - E863. [Abstract] [Full Text] [PDF]

				M. Yawata, N. Yawata, M. Draghi, A.-M. Little, F. Partheniou, and P. Parham Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function J. Exp. Med., March 20, 2006; 203(3): 633 - 645. [Abstract] [Full Text] [PDF]

				L. S. Ackerman Sex hormones and the genesis of autoimmunity. Arch Dermatol, March 1, 2006; 142(3): 371 - 376. [Abstract] [Full Text] [PDF]

				M Johansson, L Arlestig, B Moller, T Smedby, and S Rantapaa-Dahlqvist Oestrogen receptor {alpha} gene polymorphisms in systemic lupus erythematosus Ann Rheum Dis, November 1, 2005; 64(11): 1611 - 1617. [Abstract] [Full Text] [PDF]

				A. Alonso, S. S. Jick, M. J. Olek, A. Ascherio, H. Jick, and M. A. Hernan Recent Use of Oral Contraceptives and the Risk of Multiple Sclerosis Arch Neurol, September 1, 2005; 62(9): 1362 - 1365. [Abstract] [Full Text] [PDF]

				K. Huynh, G. Jones, G. Thouas, K. L. Britt, E. R. Simpson, and M. E.E. Jones Estrogen Is Not Directly Required for Oocyte Developmental Competence Biol Reprod, May 1, 2004; 70(5): 1263 - 1269. [Abstract] [Full Text] [PDF]

				B. Sinervo and R. Calsbeek Physiological Epistasis, Ontogenetic Conflict and Natural Selection on Physiology and Life History Integr. Comp. Biol., July 1, 2003; 43(3): 419 - 430. [Abstract] [Full Text] [PDF]